Managed Entry Agreements

Executive Summary

Managed access agreements are innovative pricing arrangements that allow cost or risk sharing for drugs with high prices or uncertain clinical efficacy, such as innovative or orphan products. Italy is an active user of such arrangements, which are detailed in this section.